Literature DB >> 25535176

Inverted-Takotsubo cardiomyopathy: severe refractory heart failure in poly-trauma patients saved by emergency extracorporeal life support.

Massimo Bonacchi1, Andrea Vannini2, Guy Harmelin2, Stefano Batacchi3, Marco Bugetti2, Guido Sani2, Adriano Peris3.   

Abstract

OBJECTIVES: The sequelae of severe poly-trauma may include myocardial dysfunction followed by acute heart failure and death. Inverted-Takotsubo cardiomyopathy (ITC) is a variant of stress cardiomyopathy, characterized by a contractile abnormality with extensive left ventricular circumferential dyskinesia or akinesia with a hyperkinetic apex. We report our experience with refractory cardiogenic shock and/or cardiac arrest, treated with extracorporeal life support.
METHODS: From June 2008 to December 2011, we treated 4 adult poly-trauma patients (3 men, 1 woman, mean age: 27.7 ± 13.5 years, mean ISS score 53.2 ± 15.9) with veno-arterial (V-A) extracorporeal life support for cardiopulmonary failure/cardiac arrest refractory to conventional treatment, due to inverted-Takotsubo cardiomyopathy. We used a miniaturized extracorporeal life support (ECLS) device.
RESULTS: ITC myocardial dysfunction appeared 15.4 ± 11.6 h after intensive care unit admission and rapidly evolved to refractory cardiopulmonary failure and cardiac arrest (within 4.8 ± 2.5 h of the onset). At ECLS, initiation median pH was 7.12 ± 0.14 (6.91-7.25), median lactate was 6.7 ± 2.8 (4-10) mmol/l and median vasoactive-inotropic score was 192.1 ± 50.6 µg/kg/min. Tissue perfusion improved significantly within 4 h on ECLS. Cardiac function improved gradually but consistently. Initial median ejection fraction was 14.2 ± 4.7% and median global longitudinal strain test was -7.4 ± 4.7. At complete cardiac recovery, they were 62.73 ± 7.8 and -18.43 ± 2.4%, respectively. After that, 2 patients survived and were sent to neurological rehabilitation before hospital discharge. In the other 2 cases, post-traumatic cerebral death occurred and they underwent organ explantation.
CONCLUSIONS: Rapid heparin-free ECLS may improve outcome in the most severe cases of poly-traumatized patients demonstrating refractory inverted-Takotsubo cardiomyopathy.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Cardiomyopathy; Circulatory assistance; Emergency; Heart failure; Myocardial recovery; Trauma

Mesh:

Year:  2014        PMID: 25535176     DOI: 10.1093/icvts/ivu421

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  7 in total

1.  Examining the role of extracorporeal membrane oxygenation in patients following suspected or confirmed suicide attempts: A case series.

Authors:  Adeel Abbasi; Cynthia Devers; Christopher S Muratore; Colin Harrington; Corey E Ventetuolo
Journal:  J Crit Care       Date:  2017-10-18       Impact factor: 3.425

2.  Stress Cardiomyopathy Managed with Extracorporeal Support after Self-Injection of Epinephrine.

Authors:  Bourenne Jeremy; Fresco Raphaëlle; Kerbaul François; Michelet Pierre; Gainnier Marc
Journal:  Case Rep Crit Care       Date:  2017-08-27

Review 3.  Takotsubo Cardiomyopathy in Traumatic Brain Injury.

Authors:  Chun Fai Cheah; Mario Kofler; Alois Josef Schiefecker; Ronny Beer; Gert Klug; Bettina Pfausler; Raimund Helbok
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

4.  Comparison of clinical efficacy of metoprolol combined with irbesartan and hydrochlorothiazide and non-invasive ventilator in the emergency treatment of patients with severe heart failure.

Authors:  Fangxia Zhang; Guoxia Zhou; Lisha Guo; Fei Lu; Guojun Zhou
Journal:  Exp Ther Med       Date:  2018-10-04       Impact factor: 2.447

Review 5.  Takotsubo Syndrome: Translational Implications and Pathomechanisms.

Authors:  Xuehui Fan; Guoqiang Yang; Jacqueline Kowitz; Ibrahim Akin; Xiaobo Zhou; Ibrahim El-Battrawy
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

6.  Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome.

Authors:  Albert Topf; Moritz Mirna; Christiane Dienhart; Peter Jirak; Nina Bacher; Elke Boxhammer; Sarah X Gharibeh; Lukas J Motloch; Uta C Hoppe; Michael Lichtenauer
Journal:  Biomedicines       Date:  2022-02-16

Review 7.  An Emerging Cardiovascular Disease: Takotsubo Syndrome.

Authors:  Sara Moscatelli; Fabrizio Montecucco; Federico Carbone; Alberto Valbusa; Laura Massobrio; Italo Porto; Claudio Brunelli; Gian Marco Rosa
Journal:  Biomed Res Int       Date:  2019-10-30       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.